330406
Putting PrEP into practice: PrEP providers' first-hand experiences, challenges, and solutions
Methods: U.S.-based PrEP providers were recruited via referral from colleagues and other participants (September 2014-February 2015). One-on-one, 90-minute interviews were conducted via phone or in person, transcribed, and analyzed.
Results: The sample (n=18; Meanage=43; 72% men) was diverse with respect to race (39% White/33% Asian/11% Black/17% Other), sexual orientation (56% heterosexual/44% gay), and geographic location (67% Northeast/22% South/11% other). Most were MDs (94%) and self-identified as HIV or infectious disease specialists (89%). Prior experience prescribing PrEP ranged from 2-300 patients, with many patients characterized as MSM. Providers reported considering several factors beyond CDC criteria in determining eligibility for PrEP, including local HIV epidemiology, PrEP’s potential psychosocial benefits, and patients’ underreporting of risk behavior. PrEP initiation was commonly decided using a collaborative, patient-centered approach. Providers observed that PrEP was well tolerated among most patients, with minimal adherence difficulties, increases in risk behavior, or adverse effects. Several providers highlighted the benefit of clinical staff support for patient monitoring and risk/adherence counseling. PrEP was covered for most patients via insurance, Medicaid, or other programs; however, high deductibles, lab work/service provision costs, and pre-authorization requirements sometimes presented challenges.
Conclusions: Overall, providers reported favorable experiences with PrEP initiation and management. Reported insights may be instructive for providers who are less familiar with PrEP, thereby supporting patient access.
Learning Areas:
Chronic disease management and preventionImplementation of health education strategies, interventions and programs
Provision of health care to the public
Social and behavioral sciences
Learning Objectives:
Describe healthcare providers’ early experiences with PrEP implementation in clinical practice, including prescribing considerations and logistical challenges.
Keyword(s): HIV/AIDS, Prevention
Qualified on the content I am responsible for because: I have a PhD and 10+ years of experience conducting research in the realm of HIV prevention. I am the principal investigator of an NIH-funded K01 mixed methods study aimed at promoting PrEP awareness and equitable prescription practices among healthcare providers.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.